Words: main text 3490, abstract 250 2 ABSTRACT Objectives: Neuromuscular dysfunction in critically ill patients is attributed to either critical illness myopathy (CIM) or critical illness polyneuropathy (CIP) or a combination of both. But it is unknown whether differential diagnosis has an impact on prognosis. This study investigates whether there is an association between the early differentiation of CIM versus CIP and clinical prognosis.
The study was approved by our local ethics committee. Written informed consent of legal 3 proxies was obtained according to the Declaration of Helsinki. 4 We performed this observational study in a 14-bed surgical ICU over a period of 18 months. 5 Patients who required mechanical ventilation and featured a Simplified Acute Physiology 6 Score II > 20 (SAPS-II)[17] on three consecutive days within the first 7 days after ICU 7 admission were eligible for inclusion. Pre-existing neuromuscular disorders, severe head 8 trauma or bleeding diathesis were previously defined as exclusion criteria. All patients were 9 treated according to our standard operating procedures of intensive care medicine, adopting 10 evidence based bundles for severe sepsis. [18, 19] Severity of illness was monitored daily by 11 repeated ratings of SAPS-II and Sequential Organ Failure Assessment score (SOFA).
[20] 12 13 Every three days after admission to the ICU electrophysiological bedside studies were 14 recorded by portable 2-Channel Keypoint Medtronic equipment (Skovlunde, Denmark). Once 15 either CIM or CIP was detected or once patients showed adequate awareness, diagnostic 16 testing was repeated once a week. Given that patients featured sufficient awareness at ICU 17 discharge (Ramsay score < 2) [21] , muscle strength of upper and lower limbs was evaluated 18 and graded according to the Medical Research Council score.
[22] Whenever possible, we 19 examined two proximal/distal muscles in each extremity and divided the total by the number 20 of muscles examined. 21
Motor nerve conduction velocity and compound muscle action potential amplitude after nerve 22 stimulation (neCMAP) were unilaterally performed in median, peroneal as well as in tibial 23 nerves and recorded from abductor pollicis brevis, extensor digitorum brevis and abductor 24 hallucis muscles. Sensory nerve conduction studies were unilaterally conducted in sural and 25 6 median nerves. Surface electrodes were used for stimulation and recording. In case of missing 1 recordings or in presence of oedema, subdermal electrodes were used in all patients. Nerve 2 conduction measurements were compared to normal values from age-matched individuals that 3 were provided by the neurophysiological laboratory of the Charité. 4
During sedation, electromyography was performed in deltoid, biceps brachii, extensor 5 digitorum longus, abductor pollicis brevis, rectus femoris, and tibialis anterior muscles using 6 concentric needle electrodes to assess pathological spontaneous activity. As soon as patients 7 showed sufficient awareness and voluntary muscle contraction was possible, quantitative 8 electromyography was applied whenever possible in extensor digitorum longus and tibialis 9 anterior muscles. A total of 20 different motor unit action potentials (MUAP) was sampled by 10 random insertion of a concentric needle electrode into four different regions of an examined 11 muscle, each recorded at 10ms, 50µV and filter settings of 500 Hz and 10 kHz. [ Assessment of compound muscle action potential amplitudes following direct muscle 16 stimulation (dmCMAP) was performed by longitudinal placement of either conventional 17 stimulating surface electrodes or by subdermal electrodes along muscle fibres just proximal of 18 the distal tendon insertion in case of oedema. Muscles were stimulated by gradually 19 increasing strength (from 10 to 100mA) at 1Hz and a pulse duration of 0.1ms. For recordings, 20 disposable concentric needle electrodes (length 25mm or 37mm; diameter 0,46mm) and/or 21 disposable gel surface electrodes were used and placed 15-50 mm proximal of the stimulating 22 electrode, guided by muscle twitch. Whenever no twitch was visible, the recording concentric 23 needle electrode was pointed at four different directions in order not to miss small amplitudes. 24
Muscles were assumed to be inexcitable if responses could still not be obtained. dmCMAP 25 amplitudes were measured peak to peak. Filter settings were 500 Hz and 10 kHz. Limbs' 26 temperature was ensured to be >32°C. The examination included tibialis anterior and abductor 1 pollicis brevis. According to Trojaborg and colleagues, dmCMAP amplitudes recorded by 2 concentric needle electrodes <3mV were considered to be pathologic and consistent with 3
Electrophysiological measurements of tibialis anterior and abductor pollicis brevis muscles of 5 healthy volunteers (age 22 -74 years) in our laboratory provided reference values for 6 dmCMAP amplitudes using surface electrodes (n=17) or concentric needle electrodes (n=8). 7
To assess motor CIP we calculated neCMAP/dmCMAP ratios (recorded in tibialis anterior 8 muscle with peroneal nerve stimulation at the knee AND in abductor pollicis brevis muscle 9 with median nerve stimulation at the wrist) as introduced by Rich and colleagues: ratios <0.5 10 indicate motor neuropathy; ratios >0.5 in combination with reduced dmCMAP amplitudes 11 indicate myopathy, while ratios >0.5 in presence of normal dmCMAP amplitudes display 12 normal findings.
[13] 13
To determine muscle-fibre conduction velocity (MFCV), latencies of muscle-fibre action 14 potentials were determined and calculated for the measured distance between electrodes. 15 Perpendicular position of recording needle electrodes was ensured. Responses earlier than 8 16 ms were likely to be conducted via intramuscular nerve twigs and not included. [11, 12, 14] Kaplan-Meier curves were estimated to show the cumulative incidence of different 20 electrophysiological disorders developing over time and to estimate probabilities for ICU 21 discharge after first day of awareness in CIM and CIM/CIP patients. Differences between 22
groups considering cumulative incidences were tested by univariate Log-Rank test. 23
In univariate Cox' proportional hazard regressions we tested the impact of CIM respectively 24 CIM/CIP as well as illness severity on the duration between first day of adequate awareness 25 and ICU discharge (as dependent variable). In Cox' regressions with time dependent 26 covariates, dmCMAP and SNAP amplitudes were included as indicators of myopathy 1 respectively neuropathy while repeated recordings of SAPS-II and SOFA score during 2 adequate awareness were included as indicators of illness severity. These variables were also 3 analysed by stepwise (backward) procedure of multivariate Cox' regression accounting for 4 time dependent covariates. Hazard ratios (HR) with 95%-confidence intervals (95%-CI (HR)) 5 and corresponding p-values were calculated for each risk factor. p<0.05 (two-sided) was 6 considered as statistically significant. Statistical analysis was performed using SPSS, Version 7 14, Copyright© SPSS, Inc., Chicago, Illinois 60606, USA, and SAS, Version 9.1, Copyright© 8 SAS Institute, Inc., Cary, NC, USA. 9 Results 1 2 212 patients required mechanical ventilation and featured SAPS II > 20 on three consecutive 3 days within the first 7 days after ICU admission and were therefore eligible for inclusion. 4
Patients with pre-existing neuromuscular disorder (n=24), severe head trauma (n=14) or 5 bleeding diathesis (n=33) (thrombocytopenia <20.000/µl) were excluded. 16 patients could 6 not be included due to logistical reasons. Written informed consent by legal proxy could not 7 be obtained in 72 patients. Finally, 53 patients were included and a total of 184 8 electrophysiological examinations were conducted. One or two examinations were conducted 9 in nine patients each, three exams in 12 patients and four or more examinations in 23 patients. 10
11
Patient classification is shown in Figure 1 . Only one patient with pre-existing Wilson's 12 disease and two previous liver transplantations showed reduced SNAP amplitudes without 13 evidence of motor CIP or CIM at both exams. However, pre-existing sensory polyneuropathy 14 could not be ruled out.
[26] To prevent confusion, all three patients classified as ICU 15 unspecific as well as the only patient with isolated sensory nerve involvement were not 16 considered in tables and figures. 17
18
Patients' characteristics are shown in Table 1 . 19 20 21 Amplitudes of nerve conduction studies are shown in Table 2 . Predominant involvement of 1 the lower limbs was observed in all patients. Parameters such as motor/sensory nerve 2 conduction velocity, distal motor latency or F-Wave did not deviate from normal values in 3 any of the examined patients. Pathological spontaneous activity such as fibrillation potentials 4 or positive sharp waves were mostly of moderate activity and could be observed in different 5 muscles from patients classified as "ICU unspecific", "CIM" and "CIM/CIP". Tibialis 6 anterior and extensor digitorum longus muscles were most frequently affected. 7 8 Muscle specific electrophysiological data are shown in Table 3 . In quantitative 1 electromyography we observed an increased incidence of polyphasic potentials and the 2 recruitment pattern at maximum effort was fully or only mildly reduced despite severe 3 weakness in patients classified as "CIM / CIP" respectively "CIM" indicating a myopathy. 4
We did not find signs of denervation such as a reduced recruitment pattern or elevated MUAP 5 amplitudes. 6
In healthy subjects (age 22 -74 years) dmCMAP amplitudes were not below 0.6mV when 7 recorded by surface electrodes and not below 3mV when recorded by concentric needle 8 electrodes. For surface electrodes 95% CI were between 0.9mV and 6mV for tibialis anterior 9 muscle and between 0.6mV and 20mV for abductor pollicis brevis muscle. Considering 10 concentric needle electrodes, the according 95% CI were between 4mV and 19mV and 11 between 6.8mV and 13mV, respectively. Onset of electrophysiological pathology is shown in Figure 2 . Six patients could not be 1 included in analysis due to treatment in external hospitals prior to ICU admission. Abnormal 2 dmCMAP amplitudes occured significantly earlier than abnormal SNAP (p < 0.001), 3
indicating that CIM occurs prior to CIP with associated sensory nerve involvement during 4 early critical illness. CIM patients showed reduced dmCMAP amplitudes median at day 7 5 (5/11) while CIM/CIP patients showed reduced SNAP amplitudes median at day 10 (4/13). 6
Confounders prolonging ICU length of stay showed that classification as CIM or CIM/CIP 7 independently influenced ICU length of stay whereas illness severity was comparable 8 between both groups (p=0.005) ( Table 4) . 9
Once sedation was ended, patients classified as CIM/CIP stayed significantly longer than 10 patients classified as CIM (p = 0.05) ( Figure 3 At ICU discharge, muscle strength according to the MRC-score was significantly lower in 19 patients classified as CIM/CIP (n=14; examination was precluded in 4 patients due to death 20 and in 2 patients due to logisitical reasons; mean MRC-score in upper limbs 3.5; mean MRC-21 score in lower limbs 3.25) than in patients classified as CIM (n=8; examination was precluded 1 in 6 patients due to death and in 2 patients due to logistical reasons; mean MRC-score in 2 upper limbs 4.5, p=0.002; mean MRC-score in lower limbs 4.0, p=0.004). Ne/dmCMAP ratios <0.5 are supposed to indicate motor axonopathy. [16] Since this ratio was 18 >0.5 in all of our patients the presence of motor axonopathy is questionable. Z'Graggen and 19 colleagues assessed the existence of membrane depolarization in motor nerves by applying 20 nerve excitability testing[30], proving a nerve membrane affection but not finally proving the 21 existence of a motor axonopathy. 22
It should be emphasised that SNAP abnormalities indicate sensory neuropathy and cannot 23 serve as definite evidence towards neuropathic involvement in clinical weakness. Early 24 reports attributed weakness in critically ill patients mostly to distal motor axonopathy on the 25 basis of non-specific electrophysiological abnormalities and neglected the possibility of 26 20 primary muscle fibre disorder. [3, 31] By applying the technique of direct muscle stimulation, 1 we and others, were able to show that CIM is frequent in critically ill patients.[7,11-15] 2 However, ne/dm CMAP ratios did not add further information to the diagnosis of myopathy 3 than dmCMAP amplitudes. 4 5
Clinical aspects 6
Onset and incidence of neuromuscular disorder 7
To the best of our knowledge, this is the first study reporting that CIM is verified significantly 8 earlier than CIP. Unspecific findings such as pathological spontaneous activity or reduced 9 neCMAP amplitudes do not differentiate CIM and CIP and were observed within the first 10
week after ICU admission. This is in line with three earlier studies describing early onset of 11 neuromuscular dysfunction in the ICU without differentiating between myopathy and 12 neuropathy.[9, 10, 32] We presume that early pathological spontaneous activity is related to 13 muscle membrane depolarization leading to elevated excitability. 14 Coexistance of pathological spontaneous activity and reduced dmCMAP amplitudes was 15 surprising to us, as we expected a reverse relationship due to contrary pathology. However, 16
this is in line with findings from a rat-model of CIM describing concomitant membrane 17 depolarization and reduced excitability, which was attributed to voltage-gated sodium-channel 18 dysfunction. [33, 34] It was furthermore reported, that endotoxin of gram-negative bacteria 19 causes a hyperpolarized shift in the gating of voltage-gated sodium channels in human 20 skeletal muscle, [35] which in presence of muscle membrane depolarization in critically ill 21 patients [36] will finally cause muscle membrane inexcitability. 22
We observed both systemic inflammation and illness severity during early critical illness to 23 present significant risk factors for development of CIM or CIM/CIP. It nevertheless remains 24 unresolved why some patients show more severe or combined affection of muscles and nerves 25 than others. 26
Recovery from neuromuscular disorder 1 Some authors advise against adoption of electrophysiological differential diagnosis [7, 8] since 2 distinguishing between CIM and CIP would not be associated with clinical prognosis. We 3 recently reported that CIM constitutes the primary reason for ICU acquired weakness 4 presenting in critically ill patients suffering from sepsis, systemic inflammatory response 5 syndrome or multiple organ failure once sedation is ended.
[15] For the first time we report 6 that ICU length of stay is markedly prolonged in patients classified as CIM/CIP compared to 7 patients with isolated CIM and that this does not result from illness severity after sedation was 8 ended. Expecting subsequent prolongation of recovery time, it was interesting to observe that 9 patients classified as CIM/CIP still featured severe weakness at ICU discharge in contrast to 10 CIM patients. This is consistent with observations by Guarneri and colleagues describing 11 better long-term prognosis (one year after hospital discharge) in patients diagnosed with 12 isolated CIM.
[37] It should nevertheless be mentioned that patients classified as CIM/CIP 13 showed more pronounced dmCMAP amplitude reduction and shorter MUAP duration, both 14 characteristics of pronounced myopathy, than patients with pure CIM. 15
16
As some CIM patients show recovery of dmCMAP amplitude reduction at ICU discharge, we 17 presume inactivation of voltage-gated sodium channels in structural intact muscle fibres to be 18 reversible after successful treatment/elimination of potentially involved factors, which would 19 explain return to normal function within days.[7,11,13,38] Recovery was not observed in 20 patients classified as CIM/CIP, which may be either due to pronounced muscle dysfunction 21 with selective myosin-filament loss in fast twitch muscle fibres OR due to muscle denervation 22 causing muscle membrane depolarization potentially counteracting recovery. [11, 36, 38, 39 ] 23 24 In conclusion, we were able to show that clinical prognosis differs according to 25 electrophysiological differential diagnosis during early critical illness. CIM in combination 26 22 with CIP was associated with more severe weakness at ICU discharge and longer ICU length 1 of stay than isolated CIM. During the early course of critical illness, when voluntary muscle 2 contraction is not applicable due to sedation, we recommend conventional 3 electrophysiological recordings in combination with direct muscle stimulation (adds another 4 5-15 min) to maintain precise differential diagnosis. This supports better prediction of 5 weaning difficulties which occur in both CIM and CIM/CIP patients and furthermore assists 6 clinicians in estimating motor function recovery at ICU discharge. illness. Probability 0.5 for pathological spontaneous activity (short/long dashed line n=34) is 9 median 5 days (4.82/ 7.18 95% CI), for reduction of neCMAP amplitudes (short/long dashed 10 line (n=40) 6 days (3.88 / 6.12 95% CI); for reduction of dmCMAP amplitudes (solid line, n = 11 30) 9 days (6.38 / 11.6 95% CI) and for reduction of SNAP amplitude (short dashed line, 12 (n=17) 18 days (4.01 / 31.9 95% CI). Time differences are significant for dmCMAP vs. 
